Motor Neurone Disease Trial, Recruiting NCT06765564 Sponsor: Shanghai East Hospital Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT06765564
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You (or your legal guardian) must be willing to give written consent to take part in this study.
  • You must be between 18 and 60 years old; any gender may apply.
  • You must have been officially diagnosed with ALS (Lou Gehrig's disease) using internationally recognised guidelines, and your diagnosis must have been made between 6 and 24 months before the screening date.
  • You must have already tried standard treatments that have not worked well or where your condition has continued to get worse.
  • Your lungs must be working at 50% or more of their expected capacity, based on a breathing test.
  • During the screening period, your blood oxygen levels must not fall below 90% for more than 2% of any night measured.
  • The trial doctor must consider you to be in good nutritional health, and your body weight relative to your height (BMI) must be 18.5 or above.
  • If you are a man or a woman who could become pregnant, you must agree to use effective birth control from the time you sign the consent form until one year after treatment begins.
  • You must be willing and able to attend appointments and have your medical information collected throughout the study.

Who may not be able to join:

  • You have muscle weakness symptoms but it has not been clearly confirmed that you have ALS.
  • You have been diagnosed with severe memory or thinking problems, dementia, or a serious mental health condition such as schizophrenia, bipolar disorder, or severe depression.
  • You have any other condition that affects how your nerves or muscles work, such as nerve damage in the limbs or a muscle disease caused by metabolism problems.
  • You have a history of cancer or have previously been diagnosed with any type of malignant tumour.
  • In the two weeks before screening, you had an active infection that needed treatment with antibiotics, antiviral, or antifungal medicines.
  • You have ALS and are also experiencing breathing (respiratory) failure.
  • You have previously received a transplant of cells from another person, or had an organ transplant.
  • You have taken part in another clinical trial within the three months before screening.
  • You have had a tracheostomy (a surgical opening in the throat to help breathing) or you currently use a machine to help you breathe.
  • You have a documented history of a severe allergic reaction to general anaesthesia medicines, or have had other serious allergic reactions in the past.
  • You have a brain condition that causes increased pressure inside your skull.
  • Your liver function blood tests during screening show certain abnormal results above specified levels (confirm with trial site).
  • Your kidney function blood tests during screening show certain abnormal results, such as raised creatinine levels or reduced kidney filtration rate (confirm with trial site).
  • You have other significantly abnormal laboratory test results during screening (confirm with trial site).
  • You have hepatitis A, active hepatitis B, active hepatitis C, hepatitis E, HIV, or syphilis.
  • You have reduced or impaired consciousness.
  • Your blood clotting tests show abnormal results, or you are currently taking blood-thinning (anticoagulant) medication.
  • You have high blood pressure that remains poorly controlled (above 160/100 mmHg) even with treatment.
  • You have severe diabetes with advanced complications, or another condition affecting how you move your limbs, such as severe arthritis or gout.
  • You have had surgery or a significant injury (including a broken bone) within the past month.
  • You are pregnant or currently breastfeeding.
  • The trial doctor believes you have another poorly controlled health condition or any other reason that makes it unsuitable for you to take part.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai East Hospital
Registry
ClinicalTrials.gov
Start date
13 March 2024
Est. completion
13 March 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Number of participants with adverse event (AE) and serious adverse event(SAE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov